Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
V. Amargianitakis, I. Lambiri, E. Koutala, E. Tzortzaki, A. Anagnostis, N. Tzanakis, N. Siafakas (Heraklion, Greece). Invariant natural killer Tcells (iNKT) in BAL fluid in diffuse parenchymal lung diseases: Preliminary results. Eur Respir J 2010; 36: Suppl. 54, 5227

Member's Comments

No comment yet.

Related content which might interest you: Expression of natural killer inhibitory receptors (KIR) on NK and NKT cells in the bronchoalveolar lavage fluid of sarcoidosis patients Source: Eur Respir J 2003; 22: Suppl. 45, 74s Year: 2003 Natural killer and natural killer T-like cells in bronchoalveolar lavage fluid and peripheral blood in diffuse lung diseases Source: International Congress 2016 – ILD pathogenesis Year: 2016 aEb7 integrin (CD103-b7) expression in bronchoalveolar T lymphocytes in interstitial lung diseases Source: Eur Respir J 2007; 30: Suppl. 51, 576s Year: 2007 Oligoclonal CD8 T lymphocytes accumulates in bronchoalveolar lavage of familial pulmonary alveolar microlithiasis patients Source: Eur Respir J 2006; 28: Suppl. 50, 550s Year: 2006 Analysis of T and NK lymphocyte phenotypes in patients with tuberculous pleuricy Source: Eur Respir J 2001; 18: Suppl. 33, 307s Year: 2001 Circulating natural killer T cells in patients with asthma Source: Eur Respir J 2004; 24: Suppl. 48, 352s Year: 2004 Interferon gamma (IFNgamma) decreases apoptosis rate of antigen primed T helper lymphocytes from bronchoalveolar lavage (BAL) Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013 Expression phenotypes of CD4+ and CD8+ T lymphocytes in bronchoalveolar lavage fluid and blood in lung fibrosis Source: International Congress 2014 – ILDs 2 Year: 2014 BAL regulatory T cells (Tregs) are decreased in common variable immunodeficiency (CVID) with ILD Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013 Lymphocyte subsets and NK-cells in BAL in different stages of pulmonary sarcoidosis (PS) Source: Eur Respir J 2002; 20: Suppl. 38, 469s Year: 2002 CD8+ T-cell alveolitis in familial pulmonary alveolar microlithiasis Source: Eur Respir J 2007; 30: 165-171 Year: 2007 Defective natural killer cells during lung echinococcosis Source: Eur Respir J 2003; 22: Suppl. 45, 267s Year: 2003 Characterisation of the T cell receptor repertoire (TCR) in interstitial lung and peripheral blood lymphocytes in smokers Source: Annual Congress 2004 - Insights into asthma and COPD Year: 2004 Alveolar lymphocytes (AL) in healthy individuals are mostly effector T cells. The flow cytometry (FC) lesson for interstitial lung diseases (ILD) evaluation Source: International Congress 2016 – ILD pathogenesis Year: 2016 Differences in alveolar cell populations, natural killer cells and lymphocyte subsets between pulmonary sarcoidosis (PS) and idiopathic pulmonary fibrosis (IPF) Source: Eur Respir J 2006; 28: Suppl. 50, 745s Year: 2006 Cytotoxic lymphocytes in different interstitial lung diseases Source: Eur Respir J 2003; 22: Suppl. 45, 226s Year: 2003 Exhausted T lymphocytes in chronic obstructive pulmonary disease: single-cell analysis of human lung tissue Source: Virtual Congress 2021 – Emerging new mechanisms of chronic lung disease Year: 2021 Immunohistochemical analysis of T lymphocytes (TLs) in lung tissue from patients with idiopathic pulmonary fibrosis (IPF) suggests potential role of CD8+ TLs in lung injury Source: Eur Respir J 2004; 24: Suppl. 48, 46s Year: 2004 Inflammatory process of CD8+ CD28- T cells in induced sputum from asthmatic patients Source: Eur Respir J 2005; 26: Suppl. 49, 25s Year: 2005 Recognition of pleural mesothelioma by mucin-1(950–958)/human leukocyte antigen A*0201-specific CD8+ T-cells Source: Eur Respir J 2011; 38: 1117-1126 Year: 2011